Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503761 | 0.92 | CES2 (0.39) | CES2LPAR1LPAR3TSHRFAAH | |
| SCHEMBL17361339 | 0.91 | — | — | |
| SCHEMBL27816148 | 0.85 | — | — | |
| SCHEMBL12039520 | 0.84 | CES2 (0.38) | CES2LPAR1LPAR3TSHRFAAH | |
| SCHEMBL19896624 | 0.83 | — | — | |
| SCHEMBL866821 | 0.83 | CES2 (0.37) | CES2LPAR1LPAR3TSHRFAAH | |
| SCHEMBL111778 | 0.83 | CES2 (0.37) | CES2LPAR1LPAR3TSHRFAAH | |
| SCHEMBL19213219 | 0.80 | TSHR (0.40) | CES2LPAR1LPAR3LMNATSHR | |
| SCHEMBL1262707 | 0.78 | CES2 (0.37) | CES2LPAR1LPAR3TSHRFAAH | |
| SCHEMBL1357185 | 0.75 | CES2 (0.40) | CES2LPAR1LPAR3TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230155174-A1 | LITHIUM METAL BATTERY ELECTROLYTES INCLUDING FLAME RETARDANT ADDITIVES | GM Global Technology Operations LLC (US) | 2023-05-18 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| US-20020198273-A1 | Isopropyl chloride with hydrofluorocarbon or hydrofluoroether as foam blowing agents | VULCAN CHEMICALS, DIVISION OF VULCAN MATERIALS COMPANY | 2002-12-26 | — | — | US | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-5874469-A | DRUG VEHICLE | ALCON LABORATORIES, INC. (US) | 1999-02-23 | — | — | US | claimed |
| WO-2024116789-A1 | LUBRICATING OIL COMPOSITION | 出光興産株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2024080214-A1 | METHOD FOR PRODUCING α-OLEFIN POLYMER | 出光興産株式会社 | 2024-04-18 | — | — | WO | disclosed |
| US-20230155174-A1 | LITHIUM METAL BATTERY ELECTROLYTES INCLUDING FLAME RETARDANT ADDITIVES | GM Global Technology Operations LLC (US) | 2023-05-18 | — | — | US | disclosed |
| CN-113745657-A | Electrolyte for lithium secondary battery and lithium secondary battery | 比亚迪股份有限公司 | 2021-12-03 | — | — | CN | disclosed |
| US-11024881-B2 | Electrolyte additive and lithium secondary battery comprising same | SOULBRAIN CO., LTD. (KR) | 2021-06-01 | — | — | US | disclosed |
| US-10971758-B2 | Electrolyte additive and lithium secondary battery comprising the same | SOULBRAIN CO., LTD. (KR) | 2021-04-06 | — | — | US | disclosed |
| US-10770749-B2 | Electrolyte additive and lithium secondary battery comprising the same | SOULBRAIN CO., LTD. (KR) | 2020-09-08 | — | — | US | disclosed |
| CN-1455663-A | Novel aerosol formulation containing polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-11-12 | — | — | CN | disclosed |
| US-6646020-B2 | Having no flash point or reduced combustibility; closed cell foams | VULCAN CHEMICALS A DIVISION OF VULCAN MATERIALS COMPANY | 2003-11-11 | — | — | US | disclosed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | disclosed |
| WO-2003068838-A1 | ISOPROPYL CHLORIDE WITH HYDROFLUOROCARBON OR HYDROFLUORETHER AS FOAM BLOWING AGENTS | VULCAN CHEMICALS (US) | 2003-08-21 | — | — | WO | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| US-20020198273-A1 | Isopropyl chloride with hydrofluorocarbon or hydrofluoroether as foam blowing agents | VULCAN CHEMICALS, DIVISION OF VULCAN MATERIALS COMPANY | 2002-12-26 | — | — | US | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10971758-B2 | Electrolyte additive and lithium secondary battery comprising the same | NEK9, DNMT3A, NEK6 | CES2 1502/4885LPAR1 2730/4885LPAR3 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.